Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Thomas Machnig

Long-Term Health-Related Quality of Life in Patients Treated With Subcutaneous C1-Inhibitor Replacement Therapy for the Prevention of Hereditary Angioedema Attacks

Journal of Allergy and Clinical Immunology

Allergy

Immunology

2019

English

Efficacy of Different Medical Therapies for the Treatment of Acute Laryngeal Attacks of Hereditary Angioedema Due to C1-Esterase Inhibitor Deficiency

Journal of Emergency Medicine

Emergency Medicine

2016

English

Related publications

Long-Term Safety of Subcutaneous C1-Inhibitor in the Prophylactic Treatment of Hereditary Angioedema

Journal of Allergy and Clinical Immunology

Allergy

Immunology

2019

English

Determinants of Health Related Quality of Life (HRQoL) in Adult Patients With Hereditary Angioedema Due to C1 Inhibitor Deficiency (C1-Inh-Hae)

Journal of Allergy and Clinical Immunology

Allergy

Immunology

2018

English

Quality of Life Evaluation in Hereditary Angioedema Patients on Home Plasma Derived C1 Inhibitor Infusion

Journal of Allergy and Clinical Immunology

Allergy

Immunology

2019

English

Long-Term Prophylaxis With Recombinant Human C1 Inhibitor in Patients With Hereditary Angioedema: Is Intramuscular Administration an Option?

Journal of Allergy and Clinical Immunology

Allergy

Immunology

2018

English

Home Treatment With Conestat Alfa in Attacks of Hereditary Angioedema Due to C1-Inhibitor Deficiency

World Allergy Organization Journal

English

Successful C1 Inhibitor Short-Term Prophylaxis During Redo Mitral Valve Replacement in a Patient With Hereditary Angioedema

Journal of Cardiothoracic Surgery

Cardiology

Cardiovascular Medicine

English

Home Treatment With Conestat Alfa in Attacks of Hereditary Angioedema Due to C1-Inhibitor Deficiency

Journal of Allergy and Clinical Immunology

Allergy

Immunology

2014

English

Treatment of Patients With Hereditary Angioedema With Normal C1 Inhibitor: Evaluation of 295 Patients

Journal of Allergy and Clinical Immunology

Allergy

Immunology

2019

English

Nanofiltered C1 Inhibitor Concentrate for Treatment of Hereditary Angioedema

New England Journal of Medicine

Medicine

2010

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Thomas Machnig

Long-Term Health-Related Quality of Life in Patients Treated With Subcutaneous C1-Inhibitor Replacement Therapy for the Prevention of Hereditary Angioedema Attacks

Efficacy of Different Medical Therapies for the Treatment of Acute Laryngeal Attacks of Hereditary Angioedema Due to C1-Esterase Inhibitor Deficiency

Related publications

Long-Term Safety of Subcutaneous C1-Inhibitor in the Prophylactic Treatment of Hereditary Angioedema

Determinants of Health Related Quality of Life (HRQoL) in Adult Patients With Hereditary Angioedema Due to C1 Inhibitor Deficiency (C1-Inh-Hae)

Quality of Life Evaluation in Hereditary Angioedema Patients on Home Plasma Derived C1 Inhibitor Infusion

Long-Term Prophylaxis With Recombinant Human C1 Inhibitor in Patients With Hereditary Angioedema: Is Intramuscular Administration an Option?

Home Treatment With Conestat Alfa in Attacks of Hereditary Angioedema Due to C1-Inhibitor Deficiency

Successful C1 Inhibitor Short-Term Prophylaxis During Redo Mitral Valve Replacement in a Patient With Hereditary Angioedema

Home Treatment With Conestat Alfa in Attacks of Hereditary Angioedema Due to C1-Inhibitor Deficiency

Treatment of Patients With Hereditary Angioedema With Normal C1 Inhibitor: Evaluation of 295 Patients

Nanofiltered C1 Inhibitor Concentrate for Treatment of Hereditary Angioedema